thyssenkrupp nucera Aligns with Q1 Forecast, Invests in Technology Portfolio Expansion — TradingView News

thyssenkrupp nucera Aligns with Q1 Forecast, Invests in Technology Portfolio Expansion — TradingView News


thyssenkrupp nucera AG & Co. KGaA/ Key word(s): Quarterly / Interim Statement

thyssenkrupp nucera Aligns with Q1 Forecast, Invests in Technology Portfolio Expansion

11.02.2026 / 06:59 CET/CEST

The issuer is solely responsible for the content of this announcement.

thyssenkrupp nucera Aligns with Q1 Forecast, Invests in Technology Portfolio Expansion

  • First quarter order intake and sales were below previous year’s level, as market uncertainties continue to affect the green hydrogen sector
  • A significant increase in Q2 order intake is expected following the signing of thyssenkrupp nucera’s largest chlor-alkali new construction project, valued in the high double-digit million-euro range
  • Contractually agreed customer projects in both technology areas are nearing completion
  • Improvement in gross margin due to higher-margin project mix and consistent cost management
  • Confirmation of full-year forecast for 2025/2026 with rising order intake and temporary decline in sales

Dortmund, February 11, 2026 – thyssenkrupp nucera’s business performance in the first quarter of 2025/2026 was in line with expectations. At EUR 75 million, the Group’s order intake was 21 percent below the prior-year figure (EUR 95 million). The main reasons for this were project-related delays in the Green Hydrogen (gH2) segment and a temporary decline in new orders in the Chlor-Alkali business, which are expected to pick up significantly again in the following quarters. The order backlog amounted to EUR 489 million as of December 31, 2025, compared with EUR 606 million as of September 30, 2025. As expected, the high degree of completion of contractually agreed customer projects in the two technology areas of alkaline water and Chlor-Alkali electrolysis led to a 44 percent decline in the Group’s sales to EUR 147 million (Q1 2024/2025: EUR 262 million).

Despite lower sales, thyssenkrupp nucera continued to invest consistently in innovation. The company increased its research and development expenditure by 31 percent to EUR 9 million (Q1 2024/2025: EUR 7 million). The electrolysis specialist is strengthening its technology portfolio with innovations like SOEC high-temperature electrolysis and a modular high-pressure electrolysis solution. In addition, thyssenkrupp nucera introduced a new generation of its BM (bipolar membrane) and advanced BiTAC (bipolar ion-exchange membrane process) electrolyzers, offering higher performance with simplified maintenance and installation.

Earnings before interest and taxes (EBIT) were down on the previous year’s figure of EUR 8 million at EUR–4 million. Earnings were impacted by exceptionally high fluctuations in derivative positions amounting to EUR 2 million, which offset price fluctuations in commodity inventory positions. However, an improved gross margin and consistent cost discipline were not able to fully compensate for the lower sales volume.

The financial result decreased from EUR 6 million to EUR 3 million due to low interest rates. After taxes, the net income was EUR–3 million (Q1 2024/2025: EUR 9 million). Earnings per share amounted to EUR–0.02, compared with EUR 0.07 in the same period of the previous year. The electrolysis specialist employed 1,089 people at the end of the first quarter (December 31, 2025), compared to 944 on December 31, 2024.

“Even though the market environment remains challenging, we are seeing increasingly positive market momentum, particularly in the area of green hydrogen. In the first quarter, we demonstrated that we are consistently driving forward our customer projects as agreed and further expanding our technological strength through high R&D investments and the expansion of our technology portfolio,” says Dr. Werner Ponikwar, CEO of thyssenkrupp nucera.

High sales recognition from customer projects in the Green Hydrogen segment

Order intake in the Green Hydrogen (gH2) segment amounted to EUR 5 million (Q1 2024/2025: EUR 5 million). New gH2 business remained under pressure due to project-related delays in a difficult market environment. As of December 31, 2025, the gH2 order backlog amounted to EUR 186 million, compared with EUR 259 million in the previous quarter.

Sales in the gH2 segment halved from EUR 154 million to EUR 77 million, mainly due to the high level of sales recognition from the NEOM project in Saudi Arabia, one of the world’s largest green hydrogen production projects. The biggest revenue driver was the Stegra project in Sweden, for which thyssenkrupp nucera is supplying electrolysers with an installed capacity of more than 700 MW. The lower revenue volume led to gH2 EBIT of EUR–12 million (previous year: EUR–8 million).

In January of this year, thyssenkrupp nucera also entered into a partnership with the German Society for International Cooperation (GIZ) GmbH to promote the development of the market for green hydrogen and power-to-X (PtX) in India. The aim is to tap into the potential along the entire hydrogen value chain. India is one of the fastest-growing economies in the world and will play a key role in the global energy transition. thyssenkrupp nucera already has over 80 employees in India.

New large-scale Chlor-Alkali project in the Middle East

In the Chlor-Alkali (CA) segment, thyssenkrupp nucera secured new orders worth EUR 70 million (previous year: EUR 89 million). While new construction business increased, service business was below the high level of the previous year. A major order in the high double-digit million range for a Chlor-Alkali project in the Middle East, signed in December 2025, will be reported in the order intake in the second quarter of 2025/26 as planned. It is the largest Chlor-Alkali order for a new construction project in the history of thyssenkrupp nucera. The Chlor-Alkali order backlog as of December 31, 2025, was EUR 302 million (September 30, 2025: EUR 347 million).

In the CA segment, thyssenkrupp nucera generated sales of EUR 70 million (Q1 2024/2025: EUR 108 million). The decline is primarily due to lower new construction business. Service business, on the other hand, remained at the high level of the previous year. EBIT decreased to EUR 8 million (Q1 2024/2025: EUR 16 million). Rising gross margins and consistent cost management were only able to partially offset the lower sales volume in the CA business.

“As expected, the continuing challenging market situation is reflected in our key figures. At the same time, developments in the first quarter show that we at thyssenkrupp nucera are keeping our cost structures flexible, continuously improving our margins, and investing specifically in technologies with clear future prospects. We remain well positioned and have a high level of financial resilience,” says Dr. Stefan Hahn, CFO of thyssenkrupp nucera.

Forecast

For fiscal year 2025/2026, thyssenkrupp nucera continues to expect order intake at Group level of between EUR 350 million and EUR 900 million (2024/2025: EUR 348 million). The main drivers are expected to be large new construction projects in both segments and the service business. The Executive Board forecasts sales of between EUR 500 million and EUR 600 million (2024/2025: EUR 845 million). Sales growth is expected to be driven primarily by projects that have already been contractually agreed. Consolidated EBIT is expected to be between EUR–30 million and EUR 0 million (2024/2025: EUR 2 million). The main drivers are the processing and conversion of the existing order backlog. Cost efficiency measures already initiated are expected to partially offset the lower cost coverage associated with the planned decline in revenue.

For the Green Hydrogen segment, thyssenkrupp nucera expects sales of between EUR 150 million and EUR 220 million (2024/2025: EUR 459 million). The expected sales development is largely in line with the existing order backlog. Additional orders in the gH2 segment are not expected to have a significant impact on sales until the following years. According to the forecast, EBIT will range between EUR–80 million and EUR–55 million (2024/2025: EUR–56 million). An improved gross margin due to a more favorable project mix in the AWE segment, cost savings, and a change in resource allocation between the segments are expected to partially offset the lower sales.

In the Chlor-Alkali segment, sales are expected to be between EUR 320 million and EUR 400 million (2024/2025: EUR 387 million). Sales development is based primarily on the existing order backlog. EBIT of between EUR 40 million and EUR 65 million (2024/2025: EUR 58 million) is expected for the CA segment, which will mainly result from the processing of the existing order backlog.

Note on financial figures

Explanations of the financial performance indicators used can be found on pages 31 to 32 of thyssenkrupp nucera’s 2024/2025 annual report.

thyssenkrupp nucera: Key figures for earnings and financial position (in EUR million)

in EUR millions Q1 2024/253 Q1 2025/26 Change
Order Intake 95 75 –21%
gH21 5 5 –14%
CA2 89 70 –22%
Sales 262 147 –44%
gH21 154 77 –50%
CA2 108 70 –35%
EBIT 8 –4
gH21 –8 –12 –55%
CA2 16 8 –50%
EBIT margin 3% –3% –6%P
Net Income 9 –3
Earnings per Share (in EUR)(Basic=diluted) 0.07 –0.02

1Green Hydrogen 2Chlor-Alkali electrolysis 3The figures have been retrospectively adjusted in accordance with IAS 8.41.

The signs used to indicate rates of change are based on economic aspects: Deteriorations are shown by a minus (−) sign. Very high positive and negative rates of change (≥ +100% or ≤ -100%) are indicated by ++ and −− respectively.

Further information

Financial information such as the complete financial tables (income statement, balance sheet, cash flow statement) for the first quarter 2025/2026 fiscal year are available here. The presentation, the quarterly report for 2025/2026, the corporate news, a recording of the press conference, and photos are available here.

Conference call for investors and media

As part of the publication of its results for the first quarter of fiscal year 2025/2026, thyssenkrupp nucera will hold a conference call (in English) for analysts, investors, and journalists on February 11, 2026, from 9:00 a.m. to 10:30 a.m. CET. An audio recording will be available on our IR website after the conference.

Investor inquiries:

Dr. Hendrik FingerHead of Investor RelationsPhone: +49 231 229 724 347Mail: hendrik.finger@thyssenkrupp-nucera.com 

Media inquiries:

Rita Syre Senior Media Relations and Financial Relations Manager Phone: +49 174 161 86 24Mail: rita.syre@thyssenkrupp-nucera.com

About thyssenkrupp nucera:

thyssenkrupp nucera offers world-leading technologies for high-efficiency electrolysis plants. The company has extensive in-depth knowledge in the engineering, procurement, and construction of electrochemical plants and a strong track record of more than 600 projects with a total rating of over 10 gigawatts already successfully installed. With its water electrolysis technology to produce green hydrogen, the company offers an innovative solution on an industrial scale for green value chains and an industry fueled by clean energy – a major step towards a climate-neutrality. thyssenkrupp nucera successfully made an IPO in July 2023. The shares are traded on the Frankfurt Stock Exchange. 

www.thyssenkrupp-nucera.com

 

Disclaimer for forward-looking statements

This publication may contain forward-looking statements which address key issues such as strategy, future financial results, events, competitive positions, and product developments. These forward-looking statements – like any business activity in a global environment – are always associated with uncertainty. They are subject to a number of risks, uncertainties, and other factors, including, but not limited to, those described in thyssenkrupp nucera AG & Co. KGaA’s (“thyssenkrupp nucera“) disclosures. Should one or more of these risks, uncertainties or other factors materialize, or should underlying expectations not occur or should assumptions prove incorrect, the actual results, performances, or achievements of thyssenkrupp nucera may vary materially from those described in the relevant forward-looking statements. Such forward-looking statements may be identified by words such as “expect”, “want”, “anticipate”, “intend”, “plan”, “believe”, “seek”, “estimate”, “will”, “project” or words of similar meaning. Thyssenkrupp nucera does not intend, nor does it assume any obligation, to update or revise its forward-looking statements regularly in light of developments which differ from those anticipated.

11.02.2026 CET/CEST Dissemination of a Corporate News, transmitted by EQS News – a service of EQS Group.

The issuer is solely responsible for the content of this announcement.

The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Language: English
Company: thyssenkrupp nucera AG & Co. KGaA
Freie-Vogel-Str. 385 a
44269 Dortmund
Germany
Phone: +49 231-22972-7100
E-mail: info@thyssenkrupp-nucera.com
Internet: www.thyssenkrupp-nucera.com
ISIN:
WKN: NCA000
Listed: Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate BSX
EQS News ID: 2274534
 
End of News EQS News Service

2274534 11.02.2026 CET/CEST

Disclaimer

Saving the news in databases or any forwarding of the news to third parties in a commercial context or for commercial purposes is only permitted with the prior written consent of EQS Group AG.



Source link

Compare listings

Compare